Best Immunotherapy with Keytruda (Pembolizumab) Doctors Worldwide — TOP 76

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Leading researcher in immunotherapy trials – Dr. Raphael specializes in Keytruda (Pembrolizumab) at Sourasky Medical Center.

• Principal investigator for Keytruda clinical trials in NSCLC
• Expert in genomic profiling and liquid biopsies for treatment response
• Member of International Association for the Study of Lung Cancer
• Outstanding teacher recognized by Tel-Aviv University

Dr. Buhl specializes in treating brain metastases and vascular anomalies, combining clinical expertise with groundbreaking research.

• Author of 47 scientific papers on neuropathology
• Founder of a fund dedicated to brain tumor research
• Performs minimally invasive and endoscopic neurosurgery
• Recognized expert in neuro-oncology and vascular pathologies

Principal investigator of clinical trials in cancer therapies – Dr. Sarid brings cutting-edge immunotherapy expertise to Sourasky Medical Center.

• Senior oncologist at Ichilov since 2009 with 38 years of experience in cancer treatment
• Specializes in biological cancer therapy including Keytruda applications
• Oxford-trained in cancer urology with 30+ published research articles
• Active member of ESMO and ASCO – global oncology standards

Dr. Pelles Sharon specializes in immunotherapy with Keytruda at Sourasky Medical Center, bringing extensive research and clinical expertise to cancer treatment.

• Conducted significant research on patient attitudes towards clinical trials
• Offers a wide range of advanced cancer treatments
• Experienced in various surgical and non-surgical oncology procedures
• Works at one of Israel's leading medical centers

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – a pioneer in immunotherapy research for sarcoma.

• Over 41 years of experience specializing in sarcoma and immunotherapy treatments
• ESMO faculty member for sarcoma treatment protocols
• Published extensively on immunotherapy outcomes in bone cancers
• Fellowship-trained at Institut Gustave Roussy – Europe's leading sarcoma center

Dr. Ram Ron specializes in Immunotherapy with Keytruda (Pembrolizumab) at Sourasky Medical Center (Ichilov), offering advanced treatment options.

• Special interests include cutting-edge immunotherapy treatments
• Practices at a leading medical center known for oncology
• Focused on patient-centered care with personalized treatment plans

Dr. Ron Ram has performed several hundred stem cell transplants and published over 30 scientific articles, showcasing his deep expertise in oncology.

• Board-certified in Internal Medicine, Hematology, and Medical Oncology
• Fellowship-trained at New York Medical College, Westchester Medical Center
• Published a chapter in a medical textbook
• Works at Sourasky Medical Center (Ichilov)

300+ bone marrow and umbilical blood transplantations performed – Dr. El Hasid leads pediatric oncohematology at Dana Dwek Children's Hospital.

• Head of Pediatric Oncohematology and Oncology Department
• Member of American Association for Hematology
• 50+ publications and 40 conference reports
• Trained at City of Hope Hospital in Los Angeles

Dr. Seifert leads the Breast Cancer Center at Solingen Clinic, specializing in breast-sparing surgeries and aesthetic reconstruction.

• Over 26 years of experience of experience in gynecology and breast cancer treatment
• Expert in breast-sparing techniques and plastic reconstruction
• Head of the Breast Cancer Center at Solingen Clinic
• Provides comprehensive care including psychological support

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.

• National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
• Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
• Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
• Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Solak specializes in treating various cancers, including lung and gastrointestinal cancers, with extensive training at Hacettepe University Cancer Institute.

• Completed fellowship at Hacettepe University Cancer Institute
• Worked at The University of Texas MD Anderson Cancer Center
• Specializes in breast, testicular, ovarian, and head-neck cancers
• Graduated from Hacettepe University Faculty of Medicine

Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with over 80 international publications. She works at Anadolu Medical Center.

• Member of European Society of Medical Oncology (ESMO)
• Expert in breast, gastrointestinal, and lung cancers
• Professor at Halic University in Istanbul
• Completed advanced training in melanoma and kidney cancer clinics